NASDAQ · Technology · Fiscal year endsFY ends December
DNA X Inc
SONM$2.59-0.11 (-4.07%)Today
52-week low $2.52high $11.90
78.2% below its 52-week high
What changed
The risk factors in the latest annual report, against the year before
Filings with the SEC
Every recent report
| Filed | Form | What it is | Period or event |
|---|---|---|---|
| Aug 19, 2026 | 10-Q | Quarterly report | Jun 30, 2026 |
| May 20, 2026 | 10-Q | Quarterly report | Mar 31, 2026 |
| Apr 30, 2026 | 10-K/A | Annual report (amended) | Dec 31, 2025 |
| Apr 15, 2026 | 10-K | Annual report | Dec 31, 2025 |
| Oct 31, 2025 | 10-Q | Quarterly report | Sep 30, 2025 |
| Aug 8, 2025 | 10-Q | Quarterly report | Jun 30, 2025 |
| May 12, 2025 | 10-Q | Quarterly report | Mar 31, 2025 |
| Apr 29, 2025 | 10-K/A | Annual report (amended) | Dec 31, 2024 |
| Mar 31, 2025 | 10-K | Annual report | Dec 31, 2024 |
| Nov 13, 2024 | 10-Q | Quarterly report | Sep 30, 2024 |
| Aug 9, 2024 | 10-Q | Quarterly report | Jun 30, 2024 |
| May 14, 2024 | 10-Q | Quarterly report | Mar 31, 2024 |
| Apr 26, 2024 | 10-K/A | Annual report (amended) | Dec 31, 2023 |
| Mar 27, 2024 | 10-K | Annual report | Dec 31, 2023 |
| Nov 14, 2023 | 10-Q | Quarterly report | Sep 30, 2023 |
| Aug 14, 2023 | 10-Q | Quarterly report | Jun 30, 2023 |
| May 8, 2023 | 10-Q | Quarterly report | Mar 31, 2023 |
| May 1, 2023 | 10-K/A | Annual report (amended) | Dec 31, 2022 |
| Mar 20, 2023 | 10-K | Annual report | Dec 31, 2022 |
| Nov 14, 2022 | 10-Q | Quarterly report | Sep 30, 2022 |
| Aug 12, 2022 | 10-Q | Quarterly report | Jun 30, 2022 |
| Jun 29, 2022 | 10-K/A | Annual report (amended) | Dec 31, 2021 |
| Jun 29, 2022 | 10-Q/A | Quarterly report (amended) | Sep 30, 2021 |
| Jun 29, 2022 | 10-Q/A | Quarterly report (amended) | Jun 30, 2021 |
| May 10, 2022 | 10-Q | Quarterly report | Mar 31, 2022 |
| May 2, 2022 | 10-K/A | Annual report (amended) | Dec 31, 2021 |
| Mar 21, 2022 | 10-K | Annual report | Dec 31, 2021 |
| Nov 12, 2021 | 10-Q | Quarterly report | Sep 30, 2021 |
| Aug 16, 2021 | 10-Q | Quarterly report | Jun 30, 2021 |
| Jun 16, 2021 | 10-Q/A | Quarterly report (amended) | Mar 31, 2021 |
| Jun 16, 2021 | 10-K/A | Annual report (amended) | Dec 31, 2020 |
| May 11, 2021 | 10-Q | Quarterly report | Mar 31, 2021 |
| Apr 6, 2021 | 10-K/A | Annual report (amended) | Dec 31, 2020 |
| Mar 18, 2021 | 10-K | Annual report | Dec 31, 2020 |
| Nov 12, 2020 | 10-Q | Quarterly report | Sep 30, 2020 |
| Aug 12, 2020 | 10-Q | Quarterly report | Jun 30, 2020 |
| Jun 2, 2020 | 10-K/A | Annual report (amended) | Dec 31, 2019 |
| May 14, 2020 | 10-Q | Quarterly report | Mar 31, 2020 |
| Apr 29, 2020 | 10-K/A | Annual report (amended) | Dec 31, 2019 |
| Mar 27, 2020 | 10-K | Annual report | Dec 31, 2019 |
| Nov 12, 2019 | 10-Q | Quarterly report | Sep 30, 2019 |
| Aug 13, 2019 | 10-Q | Quarterly report | Jun 30, 2019 |
| Jun 24, 2019 | 10-Q | Quarterly report | Mar 31, 2019 |
The SEC's list of DNA X Inc's recent filings reaches back to May 14, 2019; registration statements and other prospectus filings aren't shown. Every filing on EDGAR
The comparison takes Item 1A (risk factors) of the latest 10-K and of the one before it, splits each into paragraphs, and matches every paragraph to its closest counterpart by the words they share. Dates and figures are set aside, so a paragraph whose only change is the year counts as unchanged. It is done by rules, not by anyone’s reading: the sentences are the company’s own, quoted as filed.